Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy

BACKGROUND/AIMS: This study investigated the expression of nuclear factor κB (NF-κB) and the chemokine receptor (CXCR4) in patients with diffuse large B-cell lymphoma (DLBCL) who received rituximab-based therapy. METHODS: Seventy patients with DLBCL and treated with rituximab-CHOP (R-CHOP) were incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Ho Cheol, Seo, Jongwon, Kang, Byung Woog, Moon, Joon Ho, Chae, Yee Soo, Lee, Soo Jung, Lee, Yoo Jin, Han, Seoae, Seo, Sang Kyung, Kim, Jong Gwang, Sohn, Sang Kyun, Park, Tae-In
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219968/
https://www.ncbi.nlm.nih.gov/pubmed/25378977
http://dx.doi.org/10.3904/kjim.2014.29.6.785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219968/
https://www.ncbi.nlm.nih.gov/pubmed/25378977
http://dx.doi.org/10.3904/kjim.2014.29.6.785

Ejemplares similares